Correspondence 0001493152-26-013346 from FibroBiologics, Inc. (FBLG)

FibroBiologics, Inc.
Date: March 27, 2026 · CIK: 0001958777 · Accession: 0001493152-26-013346

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-294713

Date

March 31, 2026

Author

Co-Chief

Form

CORRESP

Company

FibroBiologics, Inc.

Letter

Re:

March 27, 2026

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, DC 20549

FibroBiologics, Inc.

Registration Statement on Form S-1 (File No. 333-294713), as amended – Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright & Co., LLC (" Wainwright "), solely acting as placement agent on a best efforts basis in an offering pursuant to the registration statement on Form S-1 (File No. 333-294713) (as amended, the " Registration Statement "), hereby concurs in the request by FibroBiologics, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:15 P.M. (Eastern Time), or as soon as practicable thereafter, on March 31, 2026, pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "). Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

Very
truly yours,
H.C.
WAINWRIGHT & CO., LLC

Show Raw Text

CORRESP
 1
 filename1.htm

 March
27, 2026

 VIA
EDGAR

 U.S.
Securities and Exchange Commission

 Division
of Corporation Finance

 Washington,
DC 20549

 Re:

 FibroBiologics, Inc.

 Registration Statement
 on Form S-1 (File No. 333-294713), as amended – Concurrence in Acceleration Request

 Ladies
and Gentlemen:

 H.C.
Wainwright & Co., LLC (" Wainwright "), solely acting as placement agent on a best efforts basis in an offering
pursuant to the registration statement on Form S-1 (File No. 333-294713) (as amended, the " Registration Statement "),
hereby concurs in the request by FibroBiologics, Inc. that the effective date of the above-referenced registration statement be accelerated
to 5:15 P.M. (Eastern Time), or as soon as practicable thereafter, on March 31, 2026, pursuant to Rule 461 under the Securities Act of
1933, as amended (the " Securities Act "). Wainwright affirms that it is aware of its obligations under the Securities
Act as they pertain to the best efforts offering pursuant to the Registration Statement.

 Very
 truly yours,

 H.C.
 WAINWRIGHT & CO., LLC

 By:
 /s/
 Edward Silvera

 Name:
 Edward
 Silvera

 Title:
 Co-Chief
 Executive Officer

SecProbe.io